233 related articles for article (PubMed ID: 10069455)
1. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
[TBL] [Abstract][Full Text] [Related]
2. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
Christmann M; Kaina B
J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents.
Armstrong MJ; Galloway SM
Mutat Res; 1997 Feb; 373(2):167-78. PubMed ID: 9042397
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
Liu L; Markowitz S; Gerson SL
Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
[TBL] [Abstract][Full Text] [Related]
5. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.
Shiloh Y; Becker Y
Cancer Res; 1981 Dec; 41(12 Pt 1):5114-20. PubMed ID: 7307010
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.
Levati L; Marra G; Lettieri T; D'Atri S; Vernole P; Tentori L; Lacal PM; Pagani E; Bonmassar E; Jiricny J; Graziani G
Genes Chromosomes Cancer; 1998 Oct; 23(2):159-66. PubMed ID: 9739019
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts.
Fiumicino S; Martinelli S; Colussi C; Aquilina G; Leonetti C; Crescenzi M; Bignami M
Int J Cancer; 2000 Feb; 85(4):590-6. PubMed ID: 10699935
[TBL] [Abstract][Full Text] [Related]
10. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
11. Reversal of methylation tolerance by transfer of human chromosome 2.
Aquilina G; Fiumicino S; Zijno A; Martinelli S; Overkamp WJ; Zdzienicka MZ; Oshimura M; Wild CP; Bignami M
Mutat Res; 1997 Nov; 385(2):115-26. PubMed ID: 9447233
[TBL] [Abstract][Full Text] [Related]
12. Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage.
O'Driscoll M; Martinelli S; Ciotta C; Karran P
Carcinogenesis; 1999 May; 20(5):799-804. PubMed ID: 10334196
[TBL] [Abstract][Full Text] [Related]
13. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
[TBL] [Abstract][Full Text] [Related]
14. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells.
Galloway SM; Greenwood SK; Hill RB; Bradt CI; Bean CL
Mutat Res; 1995 Apr; 346(4):231-45. PubMed ID: 7753116
[TBL] [Abstract][Full Text] [Related]
15. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrà C; Potten CS; Crescenzi M; Bignami M
J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
[TBL] [Abstract][Full Text] [Related]
16. Highly elevated ultraviolet-induced mutation frequency in isolated Chinese hamster cell lines defective in nucleotide excision repair and mismatch repair proteins.
Nara K; Nagashima F; Yasui A
Cancer Res; 2001 Jan; 61(1):50-2. PubMed ID: 11196196
[TBL] [Abstract][Full Text] [Related]
17. N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.
Aquilina G; Ceccotti S; Martinelli S; Hampson R; Bignami M
Cancer Res; 1998 Jan; 58(1):135-41. PubMed ID: 9426069
[TBL] [Abstract][Full Text] [Related]
18. Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.
Dolan ME; Norbeck L; Clyde C; Hora NK; Erickson LC; Pegg AE
Carcinogenesis; 1989 Sep; 10(9):1613-9. PubMed ID: 2766456
[TBL] [Abstract][Full Text] [Related]
19. Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells.
Claij N; te Riele H
Oncogene; 2004 Jan; 23(1):260-6. PubMed ID: 14712231
[TBL] [Abstract][Full Text] [Related]
20. Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents.
Dosch J; Christmann M; Kaina B
Carcinogenesis; 1998 Apr; 19(4):567-73. PubMed ID: 9600339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
